Association between the c.415C > T, c.52G > A, and 36_37insGGAGTC polymorphisms of NUDT 15 and thiopurine-induced leukopenia, thiopurine intolerance, and severe hair loss: an updated meta-analysis

References

• Chande N, Patton PH, Tsoulis DJ, Thomas BS, MacDonald JK. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev. 2015;10:D67. doi:10.1002/14651858.CD000067.pub3.
   Web of Science ®Google Scholar
• Timmer A, Patton PH, Chande N, McDonald JW, MacDonald JK. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2016;5:D478. doi:10.1002/14651858.CD000478.pub4.
   Web of Science ®Google Scholar
• Goldberg R, Irving PM. Toxicity and response to thiopurines in patients with inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2015;9:891–900. doi:10.1586/17474124.2015.103998725915575
   PubMed Web of Science ®Google Scholar
• Frandsen TL, Abrahamsson J, Lausen B, et al. Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study. Br J Haematol. 2011;155:244–247. doi:10.1111/j.1365-2141.2011.08835.x21848519
   PubMed Web of Science ®Google Scholar
• Schmiegelow K, Bjork O, Glomstein A, et al. Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia. J Clin Oncol. 2003;21:1332–1339. doi:10.1200/JCO.2003.04.03912663723
   PubMed Web of Science ®Google Scholar
• Kakuta Y, Kinouchi Y, Shimosegawa T. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping. J Gastroenterol. 2018;53:172–180. doi:10.1007/s00535-017-1416-029192347
   PubMed Web of Science ®Google Scholar
• Relling MV, Hancock ML, Rivera GK, et al. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J Natl Cancer Inst. 1999;91:2001–2008. doi:10.1093/jnci/91.23.200110580024
   PubMed Web of Science ®Google Scholar
• Yates CR, Krynetski EY, Loennechen T, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med. 1997;126:608–614. doi:10.7326/0003-4819-126-8-199704150-000039103127
   PubMed Web of Science ®Google Scholar
• Tai HL, Krynetski EY, Yates CR, et al. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet. 1996;58:694–702.8644731
   PubMed Web of Science ®Google Scholar
• Schmiegelow K, Forestier E, Kristinsson J, et al. Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Leukemia. 2009;23:557–564. doi:10.1038/leu.2008.31618987654
   PubMed Web of Science ®Google Scholar
• Collie-Duguid ES, Pritchard SC, Powrie RH, et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics. 1999;9:37–42.10208641
   PubMedGoogle Scholar
• Kumagai K, Hiyama K, Ishioka S, et al. Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese. Pharmacogenetics. 2001;11:275–278.11337944
   PubMedGoogle Scholar
• Takatsu N, Matsui T, Murakami Y, et al. Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2009;24:1258–1264. doi:10.1111/j.1440-1746.2009.05917.x19682195
   PubMed Web of Science ®Google Scholar
• Kim JH, Cheon JH, Hong SS, et al. Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study. J Clin Gastroenterol. 2010;44:e242–e248. doi:10.1097/MCG.0b013e3181d6baf520308917
   PubMed Web of Science ®Google Scholar
• Moriyama T, Nishii R, Perez-Andreu V, et al. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet. 2016;48:367–373. doi:10.1038/ng.350826878724
   PubMed Web of Science ®Google Scholar
• Yang JJ, Landier W, Yang W, et al. Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol. 2015;33:1235–1242. doi:10.1200/JCO.2014.59.467125624441
   PubMed Web of Science ®Google Scholar
• Yang SK, Hong M, Baek J, et al. A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat Genet. 2014;46:1017–1020. doi:10.1038/ng.306025108385
   PubMed Web of Science ®Google Scholar
• Zhang AL, Yang J, Wang H, Lu JL, Tang S, Zhang XJ. Association of NUDT15 c.415C>T allele and thiopurine-induced leukocytopenia in Asians: a systematic review and meta-analysis. Ir J Med Sci. 2017;187:145–153. doi:10.1007/s11845-017-1608-x28470355
   PubMed Web of Science ®Google Scholar
• Yin DD, Xia X, Zhang J, et al. Impact of NUDT15 polymorphisms on thiopurines-induced myelotoxicity and thiopurines tolerance dose. Oncotarget. 2017;8:13575–13585. doi:10.18632/oncotarget.1459428088792
   PubMedGoogle Scholar
• Tanaka Y, Kato M, Hasegawa D, et al. Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia. Br J Haematol. 2015;171:109–115. doi:10.1111/bjh.1351826033531
   PubMed Web of Science ®Google Scholar
• Suzuki H, Fukushima H, Suzuki R, et al. Genotyping NUDT15 can predict the dose reduction of 6-MP for children with acute lymphoblastic leukemia especially at a preschool age. J Hum Genet. 2016;61:797–801. doi:10.1038/jhg.2016.5527193222
   PubMed Web of Science ®Google Scholar
• Liang DC, Yang CP, Liu HC, et al. NUDT15 gene polymorphism related to mercaptopurine intolerance in Taiwan Chinese children with acute lymphoblastic leukemia. Pharmacogenomics J. 2015;16:536–539. doi:10.1038/tpj.2015.7526503813
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Nakadate H, Kondoh K, et al. Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia. Pharmacogenomics J. 2017;2:275–280. doi:10.1038/tpj.2017.12
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim TJ, Kim ER, et al. Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn’s disease. PLoS One. 2017;12:e188925. doi:10.1371/journal.pone.0188925
   PubMed Web of Science ®Google Scholar
• Asada A, Nishida A, Shioya M, et al. NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease. J Gastroenterol. 2016;51:22–29. doi:10.1007/s00535-015-1142-426590936
   PubMed Web of Science ®Google Scholar
• Kakuta Y, Naito T, Onodera M, et al. NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD. Pharmacogenomics J. 2015;16:280–285. doi:10.1038/tpj.2015.4326076924
   PubMed Web of Science ®Google Scholar
• Wang HH, He Y, Wang HX, et al. Comparison of TPMT and NUDT15 polymorphisms in Chinese patients with inflammatory bowel disease. World J Gastroenterol. 2018;24:941–948. doi:10.3748/wjg.v24.i8.94129491687
   PubMed Web of Science ®Google Scholar
• Sutiman N, Chen S, KL L, et al. Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients. Pharmacogenomics. 2018;19:31–43. doi:10.2217/pgs-2017-014729210335
   PubMed Web of Science ®Google Scholar
• Sato T, Takagawa T, Kakuta Y, et al. NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases. Intest Res. 2017;15:328–337. doi:10.5217/ir.2017.15.3.32828670229
   PubMed Web of Science ®Google Scholar
• Chao K, Wang X, Cao Q, et al. Combined detection of NUDT15 variants could highly predict thiopurine-induced leukopenia in Chinese patients with inflammatory bowel disease: a multicenter analysis. Inflamm Bowel Dis. 2017;23:1592–1599. doi:10.1097/MIB.000000000000114828570428
   PubMed Web of Science ®Google Scholar
• Shah SA, Paradkar M, Desai D, Ashavaid TF. Nucleoside diphosphate-linked moiety X-type motif 15 C415T variant as a predictor for thiopurine-induced toxicity in Indian patients. J Gastroenterol Hepatol. 2017;32:620–624. doi:10.1111/jgh.1349427416873
   PubMed Web of Science ®Google Scholar
• Tsuchiya A, Aomori T, Sakamoto M, et al. Effect of genetic polymorphisms of azathioprine-metabolizing enzymes on response to rheumatoid arthritis treatment. Pharmazie. 2017;72:22–28. doi:10.1691/ph.2017.679929441893
   PubMed Web of Science ®Google Scholar
• Zhu X, Wang XD, Chao K, et al. NUDT15 polymorphisms are better than thiopurine S-methyltransferase as predictor of risk for thiopurine-induced leukopenia in Chinese patients with Crohn’s disease. Aliment Pharmacol Ther. 2016;44:967–975. doi:10.1111/apt.1379627604507
   PubMed Web of Science ®Google Scholar
• Kim SY, Shin JH, Park JS, et al. NUDT15 p.R139C variant is common and strongly associated with azathioprine-induced early leukopenia and severe alopecia in Korean patients with various neurological diseases. J Neurol Sci. 2017;378:64–68. doi:10.1016/j.jns.2017.04.04128566182
   PubMed Web of Science ®Google Scholar
• Yi ES, Choi YB, Choi R, et al. NUDT15 variants cause hematopoietic toxicity with low 6-TGN levels in children with acute lymphoblastic leukemia. Cancer Res Treat. 2017;3:872–882. doi:10.4143/crt.2017.283
   Web of Science ®Google Scholar
• Moriyama T, Nishii R, Lin TN, et al. The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia. Pharmacogenet Genomics. 2017;27:236–239. doi:10.1097/FPC.000000000000028228445187
   PubMed Web of Science ®Google Scholar